D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 39,253 345 World Ranking 6074 National Ranking 265

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Lung cancer
  • Internal medicine

His primary areas of study are Lung cancer, Nuclear physics, Particle physics, Large Hadron Collider and Pathology. His biological study spans a wide range of topics, including Immunohistochemistry, Radiology and Epidermal growth factor receptor. His work in Nuclear physics covers topics such as Dark matter which are related to areas like Physics beyond the Standard Model and Pion.

In Particle physics, Fred R. Hirsch works on issues like Lepton, which are connected to Boson. He has researched Large Hadron Collider in several fields, including Standard Model, Quantum chromodynamics and Invariant mass. His study in the field of Higgs sector and Two-Higgs-doublet model also crosses realms of Standard deviation.

His most cited work include:

  • Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC (8435 citations)
  • The national lung screening trial: Overview and study design (715 citations)
  • Combined search for the Standard Model Higgs boson using up to 4.9 fb-1 of pp collision data at s=7TeV with the ATLAS detector at the LHC (569 citations)

What are the main themes of his work throughout his whole career to date?

Fred R. Hirsch mainly investigates Particle physics, Nuclear physics, Lung cancer, Atlas detector and Internal medicine. His Particle physics study which covers Lepton that intersects with Minimal Supersymmetric Standard Model. His Lung cancer research incorporates themes from Immunohistochemistry, Cancer, Epidermal growth factor receptor and Cancer research.

His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine. His studies deal with areas such as Pair production, Hadron, Quark and Branching fraction as well as Large Hadron Collider. His Pathology study integrates concerns from other disciplines, such as Lung and Adenocarcinoma.

He most often published in these fields:

  • Particle physics (37.04%)
  • Nuclear physics (33.02%)
  • Lung cancer (31.79%)

What were the highlights of his more recent work (between 2012-2021)?

  • Particle physics (37.04%)
  • Nuclear physics (33.02%)
  • Large Hadron Collider (23.15%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Particle physics, Nuclear physics, Large Hadron Collider, Lung cancer and Atlas detector. Particle physics is closely attributed to Lepton in his study. Fred R. Hirsch interconnects Boson and Higgs boson in the investigation of issues within Nuclear physics.

His research in Large Hadron Collider tackles topics such as Muon which are related to areas like Quantum chromodynamics and Electron. His Lung cancer research includes themes of Cancer and Clinical trial. His Oncology research is multidisciplinary, incorporating perspectives in Stage, Cohort and Immunotherapy.

Between 2012 and 2021, his most popular works were:

  • Observation of Associated Near-Side and Away-Side Long-Range Correlations in √sNN=5.02 TeV Proton-Lead Collisions with the ATLAS Detector (389 citations)
  • Search for dark matter candidates and large extra dimensions in events with a jet and missing transverse momentum with the ATLAS detector (195 citations)
  • Measurement of the jet radius and transverse momentum dependence of inclusive jet suppression in lead-lead collisions at √sNN=2.76 TeV with the ATLAS detector (184 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Chemotherapy

The scientist’s investigation covers issues in Nuclear physics, Particle physics, Large Hadron Collider, Pair production and Boson. Atlas detector, Top quark, Proton, Physics beyond the Standard Model and Invariant mass are among the areas of Nuclear physics where Fred R. Hirsch concentrates his study. His research in Standard Model, Supersymmetry, Higgs boson, Minimal Supersymmetric Standard Model and Neutralino are components of Particle physics.

His Minimal Supersymmetric Standard Model study combines topics from a wide range of disciplines, such as Electroweak interaction and Gaugino. His Large Hadron Collider research integrates issues from Quantum chromodynamics, Muon and Lepton. Fred R. Hirsch combines subjects such as Photon, Dark matter and Large extra dimension with his study of Pair production.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson.
Journal of Thoracic Oncology (2011)

4675 Citations

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe.
Journal of Thoracic Oncology (2015)

2376 Citations

Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

Federico Cappuzzo;Fred R. Hirsch;Elisa Rossi;Stefania Bartolini.
Journal of the National Cancer Institute (2005)

1901 Citations

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Michael V. Di Maria.
Journal of Clinical Oncology (2003)

1531 Citations

Lung cancer: current therapies and new targeted treatments

Fred R Hirsch;Giorgio V Scagliotti;James L Mulshine;Regina Kwon.
The Lancet (2017)

1114 Citations

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Wilbur A. Franklin.
Journal of Clinical Oncology (2006)

892 Citations

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch;Abigail McElhinny;Dave Stanforth;James Ranger-Moore.
Journal of Thoracic Oncology (2017)

875 Citations

Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology

Fred R. Hirsch;Wilbur A. Franklin;Adi F. Gazdar;Paul A. Bunn.
Clinical Cancer Research (2001)

752 Citations

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Christine H. Chung;Kim Ely;Loris McGavran;Marileila Varella-Garcia.
Journal of Clinical Oncology (2006)

630 Citations

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

Samir E. Witta;Robert M. Gemmill;Fred R. Hirsch;Christopher D. Coldren.
Cancer Research (2006)

553 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fred R. Hirsch

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 128

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 117

William D. Travis

William D. Travis

Memorial Sloan Kettering Cancer Center

Publications: 112

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 104

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 86

Federico Cappuzzo

Federico Cappuzzo

Azienda Unità Sanitaria Locale Della Romagna

Publications: 85

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 76

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 74

Marileila Varella-Garcia

Marileila Varella-Garcia

University of Colorado Boulder

Publications: 72

Tetsuya Mitsudomi

Tetsuya Mitsudomi

Kindai University

Publications: 72

John D. Minna

John D. Minna

The University of Texas Southwestern Medical Center

Publications: 71

Adi F. Gazdar

Adi F. Gazdar

The University of Texas Southwestern Medical Center

Publications: 69

Keith M. Kerr

Keith M. Kerr

Aberdeen Royal Infirmary

Publications: 68

Paul Hofman

Paul Hofman

Inserm : Institut national de la santé et de la recherche médicale

Publications: 67

Yasushi Yatabe

Yasushi Yatabe

Nagoya University

Publications: 66

Jacques Cadranel

Jacques Cadranel

Université Paris Cité

Publications: 65

Trending Scientists

Jan Borchers

Jan Borchers

RWTH Aachen University

Prem Sikka

Prem Sikka

University of Essex

J. Laskar

J. Laskar

Maja Systems

Matteo Meneghini

Matteo Meneghini

University of Padua

Arvind H. Shah

Arvind H. Shah

University of Manitoba

Janusz Bialek

Janusz Bialek

Skolkovo Institute of Science and Technology

Takeo Saegusa

Takeo Saegusa

Kyoto University

Andrew D. Smith

Andrew D. Smith

University of St Andrews

Veronica Massena Reis

Veronica Massena Reis

Brazilian Agricultural Research Corporation

Ernesto García

Ernesto García

Spanish National Research Council

Richard D. Newcomb

Richard D. Newcomb

Plant & Food Research

Marshall Schminke

Marshall Schminke

University of Central Florida

Glen Dunlap

Glen Dunlap

University of South Florida

Michael Dewey

Michael Dewey

King's College London

Michael Boylan-Kolchin

Michael Boylan-Kolchin

The University of Texas at Austin

Manuel Aravena

Manuel Aravena

Diego Portales University

Something went wrong. Please try again later.